Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
8 pending office actions • 6 art units • 8 examiners • 0 of 8 (0%) have an AI response strategy ready • 9 patents granted in the last 365 days
FMC Corporation currently manages 8 pending office actions within the Biotechnology & Pharmaceuticals technology area. These matters are distributed across 7 distinct examiners, showing a broad range of individual reviews for the company's applications. The prosecution activity spans 5 distinct art units, suggesting that the portfolio covers several specialized technical fields within the biotechnology sector. This distribution requires the company to navigate various examination standards and technical expertise across the patent office.
HIRT, ERIN E is the busiest examiner for the company, responsible for 2 pending office actions. This examiner is the only individual handling more than a single matter for the portfolio at this time. The distribution of 8 pending actions across 7 distinct examiners indicates that the company's applications are rarely concentrated under a single individual's review. This diversity in examiner assignments can result in different prosecution experiences for the 8 pending matters. Managing 5 distinct art units further highlights the technical breadth of the company's current patenting efforts in the biotechnology and pharmaceutical fields.
Based on the USPTO statutory response window for each pending office action. 3 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 3 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 4 (50%) |
| §112 only | 1 (12%) |
| Double-patenting + other | 1 (12%) |
| Multi-statute (no §101) | 2 (25%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| KOSAR, ANDREW D | 1 | 42.0% | +31.8% |
| COLEMAN, BRENDA LIBBY | 1 | 74.9% | +15.5% |
| HIRT, ERIN E | 1 | 40.3% | +23.0% |
| WERTZ, ASHLEE ELIZABETH | 1 | 52.9% | +42.1% |
| JANOSKO, CHASITY PAIGE | 1 | 15.9% | +63.6% |
| PAK, JOHN D | 1 | 52.4% | +37.7% |
| SCHLIENTZ, NATHAN W | 1 | 41.3% | -18.9% |
| KWON, JOHN SEUNGJAI | 1 | 45.7% | +19.3% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18127373 | SUBSTITUTED TOLYL FUNGICIDES | JANOSKO, CHASITY PAIGE | 42d overdue |
| 18856302 | NOVEL SULFONATE BENZAMIDE COMPOUNDS FOR CONTROLLING INVERTEBRATE PESTS | KOSAR, ANDREW D | — |
| 18018323 | SUBSTITUTED HALOALKYL SULFONANILIDE HERBICIDES | PAK, JOHN D | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 7 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18267619 | FUNGICIDAL OXADIAZOLES AND THEIR MIXTURES | WERTZ, ASHLEE ELIZABETH | 45d overdue |
| 18127373 | SUBSTITUTED TOLYL FUNGICIDES | JANOSKO, CHASITY PAIGE | 42d overdue |
| 18419734 | HERBICIDAL MIXTURE, COMPOSITION AND METHOD | HIRT, ERIN E | 27d |
| 18856302 | NOVEL SULFONATE BENZAMIDE COMPOUNDS FOR CONTROLLING INVERTEBRATE PESTS | KOSAR, ANDREW D | — |
| 18839283 | PROCESSES FOR THE PREPARATION OF N-(1-METHYLCYCLOPROPYL)-2-(3-PYRIDINYL)-2H-INDAZOLE-4-CARBOXAMIDE AND INTERMEDIATES THEREOF | COLEMAN, BRENDA LIBBY | — |
| 18018323 | SUBSTITUTED HALOALKYL SULFONANILIDE HERBICIDES | PAK, JOHN D | — |
| 17051926 | AQUEOUS CAPSULE SUSPENSION CONCENTRATES CONTAINING A HERBICIDAL SAFENER AND A PESTICIDAL ACTIVE SUBSTANCE | KWON, JOHN SEUNGJAI | — |
| Art Unit | Apps |
|---|---|
| 1616 | 2 |
| 1625 | 1 |
| 1612 | 1 |
| 1613 | 1 |
| 1699 | 1 |
| 1615 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18856302 | NOVEL SULFONATE BENZAMIDE COMPOUNDS FOR CONTROLLING INVERTEBRATE PESTS | KOSAR, ANDREW D | 1625 | §102§112 | Non-Final OA | — | Pending | Oct 11, 2024 |
| 18839283 | PROCESSES FOR THE PREPARATION OF N-(1-METHYLCYCLOPROPYL)-2-(3-PYRIDINYL)-2H-INDAZOLE-4-CARBOXAMIDE AND INTERMEDIATES THEREOF | COLEMAN, BRENDA LIBBY | — | §112 | Non-Final OA | — | Pending | Aug 16, 2024 |
| 18419734 | HERBICIDAL MIXTURE, COMPOSITION AND METHOD | HIRT, ERIN E | 1616 | §103 | Non-Final OA | 27d | Pending | Jan 23, 2024 |
| 18267619 | FUNGICIDAL OXADIAZOLES AND THEIR MIXTURES | WERTZ, ASHLEE ELIZABETH | 1612 | §103DP | Final Rejection | 45d overdue | Pending | Jun 15, 2023 |
| 18127373 | SUBSTITUTED TOLYL FUNGICIDES | JANOSKO, CHASITY PAIGE | 1613 | §103 | Non-Final OA | 42d overdue | Pending | Mar 28, 2023 |
| 18018323 | SUBSTITUTED HALOALKYL SULFONANILIDE HERBICIDES | PAK, JOHN D | 1699 | §102§103§112 | Final Rejection | — | Pending | Jan 27, 2023 |
| 18159265 | PYRROLIDINONES HERBICIDES | SCHLIENTZ, NATHAN W | 1616 | §103 | Final Rejection | — | Pending | Jan 25, 2023 |
| 17051926 | AQUEOUS CAPSULE SUSPENSION CONCENTRATES CONTAINING A HERBICIDAL SAFENER AND A PESTICIDAL ACTIVE SUBSTANCE | KWON, JOHN SEUNGJAI | 1615 | §103 | Non-Final OA | — | Pending | Oct 30, 2020 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial